Services
Discover
Ask a Question
Log in
Sign up
Filters
Done
Question type:
Essay
Multiple Choice
Short Answer
True False
Matching
Topic
Business
Study Set
MKTG
Exam 3: Strategic Planning for Competitive Advantage
Path 4
Access For Free
Share
All types
Filters
Study Flashcards
Practice Exam
Learn
Question 101
Multiple Choice
Novartis Novartis, a Swiss drug maker, is planning to purchase a majority stake in Zhejiang Tianyuan Bio-Pharmaceutical Company, a Chinese vaccine maker. Novartis has agreed to pay $125 million for the company, which holds a 3 percent share of China's $1 billion vaccines market. The market for vaccines is growing 20 percent or more in the developing nations of Asia, Africa, and Australasia. In the past, vaccine use has been limited to basic shots against diseases such as polio, tuberculosis, and measles, but as the economies of these countries grow, government and private healthcare spending focuses on preventing diseases such as hepatitis B, cholera and rotavirus, tetanus, and others. Some critics are against the acquisition, claiming that prices will increase. Novartis claims it is not interested in raising prices but rather in expanding Tianyuan's product offerings. -Refer to Novartis.Novartis is creating and maintaining a fit between its objectives and resources and evolving market opportunities in developing countries.Novartis is engaging in:
Question 102
Multiple Choice
Russell Athletic,which is part of Berkshire Hathaway,Inc.,is a market leader in sports apparel,an industry that is growing rapidly.Russell Athletic is an example of a(n) _____ according to the portfolio matrix.